Minimizing surfactant wastage on transport

Background: Surfactant replacement therapy decreases pulmonary morbidity and mortality in premature infants with respiratory distress syndrome. It may also benefit patients with conditions associated with surfactant inactivation and secondary dysfunction, such as acute respiratory distress syndrome....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatrics (Evanston) 2019-08, Vol.144 (2_MeetingAbstract), p.872-872
Hauptverfasser: Morgan, Alyssa, Kuo, Sheree, Takenaka, Wayne, Tadaki, Kyle
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 872
container_issue 2_MeetingAbstract
container_start_page 872
container_title Pediatrics (Evanston)
container_volume 144
creator Morgan, Alyssa
Kuo, Sheree
Takenaka, Wayne
Tadaki, Kyle
description Background: Surfactant replacement therapy decreases pulmonary morbidity and mortality in premature infants with respiratory distress syndrome. It may also benefit patients with conditions associated with surfactant inactivation and secondary dysfunction, such as acute respiratory distress syndrome. Specialty Neonatal and Pediatric Transport Teams often carry surfactant when the patient condition potentially warrants administration. Because surfactant replacement therapy is costly, proper storage and handling is essential to minimize wastage. Without a process in place to maintain proper refrigeration of surfactant on transport, all vials of surfactant were discarded after our Transport Team returned their medications to the pharmacy. A pharmacy audit revealed that an average of 25-30 vials were wasted per month between January-June 2016 (estimated loss of $9k-$11k/month), prompting the following quality improvement project. AIM Statement We aim to decrease surfactant vial wastage on transport by 60% within the next 24 months by implementing a new process to track warmed surfactant vials after they are returned to the pharmacy and minimize warming of surfactant on transports. Methods A multidisciplinary team (RN, RT, MD, management, pharmacist) was assembled to brainstorm how best to address surfactant wastage. Following review of the manufacturer's package insert, a new labeling/tracking system was implemented to identify vials that had been warmed once and returned to inventory. Process mapping of the current process for taking surfactant on transport helped to identify potential barriers to process change in the context of existing Transport Team workflow. Use of a cooler to maintain refrigeration of surfactant on transport was then proposed. Numerous tests of change (Plan-do-study-act cycles) were performed to refine the type of cooler used, packaging details, and medication request process. Finally, a new algorithm for restocking surfactant to general inventory (if returned within recommended storage temperatures) vs. NICU inventory (if returned warmed once) was implemented to further minimize waste. Results Early audit of surfactant temperatures following transport using a cooler revealed that 100% of vials returned within the manufacturer's recommended storage temperature range (data not shown). Over the past 21 months, surfactant wastage has decreased from 100% in the baseline data collection period to 9.6% during project year 1 and 2.8% during pro
doi_str_mv 10.1542/peds.144.2MA9.872
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2287081958</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2287081958</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1132-cf40c7b0e3841435dc523d7f1a2616961c9f3b3c5d8bf50ceb7b97aacafeeab03</originalsourceid><addsrcrecordid>eNot0EtLxDAUBeAgCtbRH-Cu4E5ovTePJl0Ogy-YwY2uQ5omQwcnrUmL6K-3ZVydzeEc-Ai5RShRcPowuDaVyHlJd-u6VJKekQyhVgWnUpyTDIBhwQHEJblK6QAAXEiakftdF7pj99uFfZ6m6I0dTRjzb5NGs3d5H_IxmpCGPo7X5MKbz-Ru_nNFPp4e3zcvxfbt-XWz3hYWkdHCeg5WNuCY4siZaK2grJUeDa2wqiu0tWcNs6JVjRdgXSObWhpjjXfONMBW5O60O8T-a3Jp1Id-imG-1JQqCQproeYWnlo29ilF5_UQu6OJPxpBLyR6IdEziV5I9EzC_gDaWlV4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2287081958</pqid></control><display><type>article</type><title>Minimizing surfactant wastage on transport</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Morgan, Alyssa ; Kuo, Sheree ; Takenaka, Wayne ; Tadaki, Kyle</creator><creatorcontrib>Morgan, Alyssa ; Kuo, Sheree ; Takenaka, Wayne ; Tadaki, Kyle</creatorcontrib><description>Background: Surfactant replacement therapy decreases pulmonary morbidity and mortality in premature infants with respiratory distress syndrome. It may also benefit patients with conditions associated with surfactant inactivation and secondary dysfunction, such as acute respiratory distress syndrome. Specialty Neonatal and Pediatric Transport Teams often carry surfactant when the patient condition potentially warrants administration. Because surfactant replacement therapy is costly, proper storage and handling is essential to minimize wastage. Without a process in place to maintain proper refrigeration of surfactant on transport, all vials of surfactant were discarded after our Transport Team returned their medications to the pharmacy. A pharmacy audit revealed that an average of 25-30 vials were wasted per month between January-June 2016 (estimated loss of $9k-$11k/month), prompting the following quality improvement project. AIM Statement We aim to decrease surfactant vial wastage on transport by 60% within the next 24 months by implementing a new process to track warmed surfactant vials after they are returned to the pharmacy and minimize warming of surfactant on transports. Methods A multidisciplinary team (RN, RT, MD, management, pharmacist) was assembled to brainstorm how best to address surfactant wastage. Following review of the manufacturer's package insert, a new labeling/tracking system was implemented to identify vials that had been warmed once and returned to inventory. Process mapping of the current process for taking surfactant on transport helped to identify potential barriers to process change in the context of existing Transport Team workflow. Use of a cooler to maintain refrigeration of surfactant on transport was then proposed. Numerous tests of change (Plan-do-study-act cycles) were performed to refine the type of cooler used, packaging details, and medication request process. Finally, a new algorithm for restocking surfactant to general inventory (if returned within recommended storage temperatures) vs. NICU inventory (if returned warmed once) was implemented to further minimize waste. Results Early audit of surfactant temperatures following transport using a cooler revealed that 100% of vials returned within the manufacturer's recommended storage temperature range (data not shown). Over the past 21 months, surfactant wastage has decreased from 100% in the baseline data collection period to 9.6% during project year 1 and 2.8% during project year 2 (Figure 1). Discussion To date, our project results have exceeded our initial goal of decreasing surfactant vial wastage by the transport team. Moreover, efforts to conserve surfactant extended beyond the transport team to hospital practices. Multidisciplinary involvement (in particular by pharmacy) is felt to be one of the main reasons for our project's success. Use of the cooler on transport is now being considered for other medications that require refrigeration to decrease wastage.</description><identifier>ISSN: 0031-4005</identifier><identifier>EISSN: 1098-4275</identifier><identifier>DOI: 10.1542/peds.144.2MA9.872</identifier><language>eng</language><publisher>Evanston: American Academy of Pediatrics</publisher><subject>Data collection ; Inactivation ; Infants ; Morbidity ; Neonates ; Packaging ; Patients ; Pediatrics ; Pharmacy ; Quality control ; Refrigeration ; Respiratory distress syndrome ; Respiratory therapy ; Storage temperature ; Surfactants ; Workflow</subject><ispartof>Pediatrics (Evanston), 2019-08, Vol.144 (2_MeetingAbstract), p.872-872</ispartof><rights>Copyright American Academy of Pediatrics Aug 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Morgan, Alyssa</creatorcontrib><creatorcontrib>Kuo, Sheree</creatorcontrib><creatorcontrib>Takenaka, Wayne</creatorcontrib><creatorcontrib>Tadaki, Kyle</creatorcontrib><title>Minimizing surfactant wastage on transport</title><title>Pediatrics (Evanston)</title><description>Background: Surfactant replacement therapy decreases pulmonary morbidity and mortality in premature infants with respiratory distress syndrome. It may also benefit patients with conditions associated with surfactant inactivation and secondary dysfunction, such as acute respiratory distress syndrome. Specialty Neonatal and Pediatric Transport Teams often carry surfactant when the patient condition potentially warrants administration. Because surfactant replacement therapy is costly, proper storage and handling is essential to minimize wastage. Without a process in place to maintain proper refrigeration of surfactant on transport, all vials of surfactant were discarded after our Transport Team returned their medications to the pharmacy. A pharmacy audit revealed that an average of 25-30 vials were wasted per month between January-June 2016 (estimated loss of $9k-$11k/month), prompting the following quality improvement project. AIM Statement We aim to decrease surfactant vial wastage on transport by 60% within the next 24 months by implementing a new process to track warmed surfactant vials after they are returned to the pharmacy and minimize warming of surfactant on transports. Methods A multidisciplinary team (RN, RT, MD, management, pharmacist) was assembled to brainstorm how best to address surfactant wastage. Following review of the manufacturer's package insert, a new labeling/tracking system was implemented to identify vials that had been warmed once and returned to inventory. Process mapping of the current process for taking surfactant on transport helped to identify potential barriers to process change in the context of existing Transport Team workflow. Use of a cooler to maintain refrigeration of surfactant on transport was then proposed. Numerous tests of change (Plan-do-study-act cycles) were performed to refine the type of cooler used, packaging details, and medication request process. Finally, a new algorithm for restocking surfactant to general inventory (if returned within recommended storage temperatures) vs. NICU inventory (if returned warmed once) was implemented to further minimize waste. Results Early audit of surfactant temperatures following transport using a cooler revealed that 100% of vials returned within the manufacturer's recommended storage temperature range (data not shown). Over the past 21 months, surfactant wastage has decreased from 100% in the baseline data collection period to 9.6% during project year 1 and 2.8% during project year 2 (Figure 1). Discussion To date, our project results have exceeded our initial goal of decreasing surfactant vial wastage by the transport team. Moreover, efforts to conserve surfactant extended beyond the transport team to hospital practices. Multidisciplinary involvement (in particular by pharmacy) is felt to be one of the main reasons for our project's success. Use of the cooler on transport is now being considered for other medications that require refrigeration to decrease wastage.</description><subject>Data collection</subject><subject>Inactivation</subject><subject>Infants</subject><subject>Morbidity</subject><subject>Neonates</subject><subject>Packaging</subject><subject>Patients</subject><subject>Pediatrics</subject><subject>Pharmacy</subject><subject>Quality control</subject><subject>Refrigeration</subject><subject>Respiratory distress syndrome</subject><subject>Respiratory therapy</subject><subject>Storage temperature</subject><subject>Surfactants</subject><subject>Workflow</subject><issn>0031-4005</issn><issn>1098-4275</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNot0EtLxDAUBeAgCtbRH-Cu4E5ovTePJl0Ogy-YwY2uQ5omQwcnrUmL6K-3ZVydzeEc-Ai5RShRcPowuDaVyHlJd-u6VJKekQyhVgWnUpyTDIBhwQHEJblK6QAAXEiakftdF7pj99uFfZ6m6I0dTRjzb5NGs3d5H_IxmpCGPo7X5MKbz-Ru_nNFPp4e3zcvxfbt-XWz3hYWkdHCeg5WNuCY4siZaK2grJUeDa2wqiu0tWcNs6JVjRdgXSObWhpjjXfONMBW5O60O8T-a3Jp1Id-imG-1JQqCQproeYWnlo29ilF5_UQu6OJPxpBLyR6IdEziV5I9EzC_gDaWlV4</recordid><startdate>20190801</startdate><enddate>20190801</enddate><creator>Morgan, Alyssa</creator><creator>Kuo, Sheree</creator><creator>Takenaka, Wayne</creator><creator>Tadaki, Kyle</creator><general>American Academy of Pediatrics</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7TS</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>U9A</scope></search><sort><creationdate>20190801</creationdate><title>Minimizing surfactant wastage on transport</title><author>Morgan, Alyssa ; Kuo, Sheree ; Takenaka, Wayne ; Tadaki, Kyle</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1132-cf40c7b0e3841435dc523d7f1a2616961c9f3b3c5d8bf50ceb7b97aacafeeab03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Data collection</topic><topic>Inactivation</topic><topic>Infants</topic><topic>Morbidity</topic><topic>Neonates</topic><topic>Packaging</topic><topic>Patients</topic><topic>Pediatrics</topic><topic>Pharmacy</topic><topic>Quality control</topic><topic>Refrigeration</topic><topic>Respiratory distress syndrome</topic><topic>Respiratory therapy</topic><topic>Storage temperature</topic><topic>Surfactants</topic><topic>Workflow</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Morgan, Alyssa</creatorcontrib><creatorcontrib>Kuo, Sheree</creatorcontrib><creatorcontrib>Takenaka, Wayne</creatorcontrib><creatorcontrib>Tadaki, Kyle</creatorcontrib><collection>CrossRef</collection><collection>Physical Education Index</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><jtitle>Pediatrics (Evanston)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Morgan, Alyssa</au><au>Kuo, Sheree</au><au>Takenaka, Wayne</au><au>Tadaki, Kyle</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Minimizing surfactant wastage on transport</atitle><jtitle>Pediatrics (Evanston)</jtitle><date>2019-08-01</date><risdate>2019</risdate><volume>144</volume><issue>2_MeetingAbstract</issue><spage>872</spage><epage>872</epage><pages>872-872</pages><issn>0031-4005</issn><eissn>1098-4275</eissn><abstract>Background: Surfactant replacement therapy decreases pulmonary morbidity and mortality in premature infants with respiratory distress syndrome. It may also benefit patients with conditions associated with surfactant inactivation and secondary dysfunction, such as acute respiratory distress syndrome. Specialty Neonatal and Pediatric Transport Teams often carry surfactant when the patient condition potentially warrants administration. Because surfactant replacement therapy is costly, proper storage and handling is essential to minimize wastage. Without a process in place to maintain proper refrigeration of surfactant on transport, all vials of surfactant were discarded after our Transport Team returned their medications to the pharmacy. A pharmacy audit revealed that an average of 25-30 vials were wasted per month between January-June 2016 (estimated loss of $9k-$11k/month), prompting the following quality improvement project. AIM Statement We aim to decrease surfactant vial wastage on transport by 60% within the next 24 months by implementing a new process to track warmed surfactant vials after they are returned to the pharmacy and minimize warming of surfactant on transports. Methods A multidisciplinary team (RN, RT, MD, management, pharmacist) was assembled to brainstorm how best to address surfactant wastage. Following review of the manufacturer's package insert, a new labeling/tracking system was implemented to identify vials that had been warmed once and returned to inventory. Process mapping of the current process for taking surfactant on transport helped to identify potential barriers to process change in the context of existing Transport Team workflow. Use of a cooler to maintain refrigeration of surfactant on transport was then proposed. Numerous tests of change (Plan-do-study-act cycles) were performed to refine the type of cooler used, packaging details, and medication request process. Finally, a new algorithm for restocking surfactant to general inventory (if returned within recommended storage temperatures) vs. NICU inventory (if returned warmed once) was implemented to further minimize waste. Results Early audit of surfactant temperatures following transport using a cooler revealed that 100% of vials returned within the manufacturer's recommended storage temperature range (data not shown). Over the past 21 months, surfactant wastage has decreased from 100% in the baseline data collection period to 9.6% during project year 1 and 2.8% during project year 2 (Figure 1). Discussion To date, our project results have exceeded our initial goal of decreasing surfactant vial wastage by the transport team. Moreover, efforts to conserve surfactant extended beyond the transport team to hospital practices. Multidisciplinary involvement (in particular by pharmacy) is felt to be one of the main reasons for our project's success. Use of the cooler on transport is now being considered for other medications that require refrigeration to decrease wastage.</abstract><cop>Evanston</cop><pub>American Academy of Pediatrics</pub><doi>10.1542/peds.144.2MA9.872</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0031-4005
ispartof Pediatrics (Evanston), 2019-08, Vol.144 (2_MeetingAbstract), p.872-872
issn 0031-4005
1098-4275
language eng
recordid cdi_proquest_journals_2287081958
source EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Data collection
Inactivation
Infants
Morbidity
Neonates
Packaging
Patients
Pediatrics
Pharmacy
Quality control
Refrigeration
Respiratory distress syndrome
Respiratory therapy
Storage temperature
Surfactants
Workflow
title Minimizing surfactant wastage on transport
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T20%3A04%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Minimizing%20surfactant%20wastage%20on%20transport&rft.jtitle=Pediatrics%20(Evanston)&rft.au=Morgan,%20Alyssa&rft.date=2019-08-01&rft.volume=144&rft.issue=2_MeetingAbstract&rft.spage=872&rft.epage=872&rft.pages=872-872&rft.issn=0031-4005&rft.eissn=1098-4275&rft_id=info:doi/10.1542/peds.144.2MA9.872&rft_dat=%3Cproquest_cross%3E2287081958%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2287081958&rft_id=info:pmid/&rfr_iscdi=true